Security key
501575104
Kymera Therapeutics, Inc. - COMMON STOCK (KYMR)
CUSIP: 501575104
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 78,801,021
- Total 13F value
- $3,438,754,240
- Share change
- +5,986,029
- Put/Call ratio
- 36%
- SEC-reported price per share
- $43.64
- Number of holders
- 208
- Value change
- +$270,821,262
- Number of buys
- 131
- Number of sells
- 76
- Shares outstanding
- 81,496,373
Holder snapshot
7 signals
Open 1 more signal
Security identity
Who this page is about.
1 source field
Report period
Q2 2025
Institutions
208
Top holders
10
KYMR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Kymera Therapeutics, Inc. SEC filings
Kymera Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 501575104
Recent filing periods:
Ownership snapshot
Top reported holders of KYMR - Kymera Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
13F
Lead comparable stake: 5.4%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 5.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
5.4%
PRICE T ROWE ASSOCIATES INC /MD/
8.2%
Avoro Capital Advisors LLC
7.9%
WELLINGTON MANAGEMENT GROUP LLP
7.4%
BAKER BROS. ADVISORS LP
7.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
Company
|
5.4%
|
$165,983,856
3,803,227 shares
|
$0 | 30 Jun 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
8.2%
|
$183,448,000
6,702,450 shares
|
— | 31 Mar 2025 |
| Avoro Capital Advisors LLC |
13F
Company
|
7.9%
|
$176,810,200
6,460,000 shares
|
— | 31 Mar 2025 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
7.4%
|
$164,134,413
5,996,873 shares
|
— | 31 Mar 2025 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
7.4%
|
$164,108,577
5,995,929 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
6.4%
|
$143,183,198
5,231,392 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
208
Shares
78,801,021
Rows available
208
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
171
Q2 2025 holders
208
Holder diff
37
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend